Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Dear Doctor Letter (Rote-Hand-Brief) on Revlimid® (lenalidomide): New important information on reactivation of virus infections
2016.11.08
Active substance: lenalidomide
The company Celgene GmbH is circulating information that cases of virus reactivation after treatment with lenalidomide have been reported.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN